Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magali Svrcek

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
Gastroenterology|May 16, 2021
Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch RepairToky Ratovomanana, Romain Cohen, Magali Svrcek, et al.
Gastroenterology|June 19, 2012
Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinomaRaphaël Maréchal, Jean-Baptiste Bachet, John R Mackey, et al.
Journal of the National Cancer Institute|September 20, 2017
The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon TumorsLaetitia Marisa, Magali Svrcek, Ada Collura, et al.
International Journal of Cancer|November 1, 2023
Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resectionAbderaouf Hamza, Julien Masliah-Planchon, Cindy Neuzillet, et al.
Inflammatory Bowel Diseases|July 17, 2014
Small bowel adenocarcinomas complicating Crohn's disease are associated with dysplasia: a pathological and molecular studyMagali Svrcek, Gael Piton, Jacques Cosnes, et al.
Journal for Immunotherapy of Cancer|February 3, 2022
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancersGiovanni Fucà, Romain Cohen, Sara Lonardi, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 29, 2026
Risk prediction model for high-grade dysplasia in resected pancreatic mucinous cystic neoplasms: a nomogram-based approachLina Aguilera Munoz, Lucie Laurent, Sandra Salmeron, et al.
Nature Medicine|September 28, 2011
Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosisCoralie Dorard, Aurélie de Thonel, Ada Collura, et al.
Annals of Surgery|July 20, 2022
Management of Pathogenic CDH1 Variant Carriers Within the FREGAT Network: A Multicentric Retrospective StudyCapucine Bres, Thibault Voron, Leonor Benhaim, et al.
Journal of Medical Genetics|August 29, 2022
First estimates of diffuse gastric cancer risks for carriers of <i>CTNNA1</i> germline pathogenic variantsMarie Coudert, Youenn Drouet, Hélène Delhomelle, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Gastroenterology|May 16, 2021
Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch RepairToky Ratovomanana, Romain Cohen, Magali Svrcek, et al.
Gastroenterology|June 19, 2012
Levels of gemcitabine transport and metabolism proteins predict survival times of patients treated with gemcitabine for pancreatic adenocarcinomaRaphaël Maréchal, Jean-Baptiste Bachet, John R Mackey, et al.
Journal of the National Cancer Institute|September 20, 2017
The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon TumorsLaetitia Marisa, Magali Svrcek, Ada Collura, et al.
International Journal of Cancer|November 1, 2023
Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resectionAbderaouf Hamza, Julien Masliah-Planchon, Cindy Neuzillet, et al.
Inflammatory Bowel Diseases|July 17, 2014
Small bowel adenocarcinomas complicating Crohn's disease are associated with dysplasia: a pathological and molecular studyMagali Svrcek, Gael Piton, Jacques Cosnes, et al.
Journal for Immunotherapy of Cancer|February 3, 2022
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancersGiovanni Fucà, Romain Cohen, Sara Lonardi, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 29, 2026
Risk prediction model for high-grade dysplasia in resected pancreatic mucinous cystic neoplasms: a nomogram-based approachLina Aguilera Munoz, Lucie Laurent, Sandra Salmeron, et al.
Nature Medicine|September 28, 2011
Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosisCoralie Dorard, Aurélie de Thonel, Ada Collura, et al.
Annals of Surgery|July 20, 2022
Management of Pathogenic CDH1 Variant Carriers Within the FREGAT Network: A Multicentric Retrospective StudyCapucine Bres, Thibault Voron, Leonor Benhaim, et al.
Journal of Medical Genetics|August 29, 2022
First estimates of diffuse gastric cancer risks for carriers of <i>CTNNA1</i> germline pathogenic variantsMarie Coudert, Youenn Drouet, Hélène Delhomelle, et al.
Pageof 17